These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6955253)

  • 1. [Primary structure of class II human histocompatibility antigens. 2nd Communication. Amino acid sequence of the N-terminal 179 residues of the alpha-chain of an HLA-Dw2/DR2 alloantigen (author's transl)].
    Yang C; Kratzin H; Götz H; Thinnes FP; Kruse T; Egert G; Pauly E; Kölbel S; Wernet P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1982 Jun; 363(6):671-6. PubMed ID: 6955253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary structure of class II human histocompatibility antigens. 1st communication. Amino acid sequence of the N-terminal 198 residues of the beta chain of a HLA-Dw2,2;DR2,2-alloantigen (author's transl)].
    Kratzin H; Yang CY; Götz H; Pauly E; Kölbel S; Egert G; Thinnes FP; Wernet P; Altevogt P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1665-9. PubMed ID: 6947956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary structure of human class II histocompatibility antigens (HLA-D). II. Separation of alpha from beta-chains of HLA-D from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2,2;MT1,1;DC1,1;MB1,1), and characterization of the isolated chain].
    Egert G; Thinnes FP; Götz H; Pauly E; Kratzin H; Yang CY; Kölbel S; Altevogt P; Wernet P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1291-308. PubMed ID: 6334639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary structure of human class II histocompatibility antigens (HLA-D). I. Isolation, purification and characterization of the HLA-D alpha/beta chain complex from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2, 2;DR2,2;MT1,1;DC1,1;MB1,1].
    Thinnes FP; Egert G; Götz H; Pauly E; Altevogt P; Kölbel S; Wernet P; Kratzin H; Yang C; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1277-89. PubMed ID: 6334638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary structure of human class II histocompatibility antigens 3rd communication. Amino acid sequence comparison between DR and DC subclass antigens derived from a lymphoblastoid B cell line homozygous at the HLA loci (HLA-A3,3; B7,7; Dw2,2; DR2,2: MT1,1; Dc1,1: MB1,1).
    Götz H; Kratzin H; Thinnes FP; Yang C; Kruse T; Pauly E; Kölbel S; Egert G; Wernet P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1983 Jun; 364(6):749-55. PubMed ID: 6576979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal amino acid sequence analyses of the alpha and beta polypeptides from four distinct subsets of sheep major histocompatibility complex class II molecules.
    Puri NK; Walker ID; Brandon MR
    J Immunol; 1987 Nov; 139(9):2996-3002. PubMed ID: 3478413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
    Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
    J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cDNA cloning and sequencing reveals that the electrophoretically constant DR beta 2 molecules, as well as the variable DR beta 1 molecules, from HLA-DR2 subtypes have different amino acid sequences including a hypervariable region for a functionally important epitope.
    Wu SK; Yabe T; Madden M; Saunders TL; Bach FH
    J Immunol; 1987 May; 138(9):2953-9. PubMed ID: 3571980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hard alpha-keratin intermediate filament chains: substructure of the N- and C-terminal domains and the predicted structure and function of the C-terminal domains of type I and type II chains.
    Parry DA; North AC
    J Struct Biol; 1998; 122(1-2):67-75. PubMed ID: 9724606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extracellular region of light chains from human and murine MHC class II antigens consists of two domains.
    Kaufman JF; Strominger JL
    J Immunol; 1983 Feb; 130(2):808-17. PubMed ID: 6401306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis.
    Penzotti JE; Doherty D; Lybrand TP; Nepom GT
    J Autoimmun; 1996 Apr; 9(2):287-93. PubMed ID: 8738976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two-dimensional gel analyses of HLA-D region antigens by the use of monoclonal antibodies].
    Takenouchi T
    Hokkaido Igaku Zasshi; 1983 May; 58(3):279-91. PubMed ID: 6194092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of class II histocompatibility antigens isolated from a human lymphoblastoid B cell line homozygous at the HLA loci (HLA-A3, 3; B7, 7; Dw2, 2; DR2,2; DC1,1; MB1,1; MT1,1).
    Kratzin H; Yang CY; Götz H; Thinnes FP; Kruse T; Egert G; Pauly E; Kölbel S; Wernet P; Hilschmann N
    Hum Immunol; 1983 Sep; 8(1):65-73. PubMed ID: 6415000
    [No Abstract]   [Full Text] [Related]  

  • 16. The continuous antigenic regions in the second domain of the beta chain of human MHC DR2 antigen: antigenic profile of the entire extracellular part of the chain.
    Atassi H; Ulrich RG; Atassi MZ
    Eur J Immunol; 1987 Jun; 17(6):769-73. PubMed ID: 2439349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial N-terminal sequence analysis of DRw53 antigens: the beta-chains of DRw53 antigens are structurally distinct from beta-chains of DR and DQ antigens.
    Obata F; Endo T; Tate G; Miyokawa N; Katagiri M; Kashiwagi N
    J Immunol; 1986 Mar; 136(6):2187-90. PubMed ID: 3456389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary structural variation among serologically indistinguishable DS antigens: the MB3-bearing molecule in DR4 cells differs from the MB3-bearing molecule in DR5 cells.
    Giles RC; Hurley CK; Capra JD
    J Immunol; 1984 Jul; 133(1):1-3. PubMed ID: 6609970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.
    Newcomb JR; Cresswell P
    J Immunol; 1993 Jan; 150(2):499-507. PubMed ID: 8419482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
    Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
    Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.